Peer Reviewed
This review explores cytopenia after CAR T-cell therapy, including its risk stratification and management with growth factors, thrombopoietin-receptor agonists, and hematopoietic stem cell boosts.
Brijesh Gautama, MPharm (Hons), MSc, PGDip
Advertisement
Articles by Brijesh Gautama, MPharm (Hons), MSc, PGDip
Advertisement
Latest Updated Articles
Management of Cytopenia Post CAR T-Cell TherapyAugust 15th 2024
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updated 2025-2026 COVID-19 Vaccine Nearly Halved ED Visits, Hospitalizations in CDC-Funded Study
2
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
3
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
4
The Biosimilar Conversation Nobody Is Having at the Pharmacy Counter: Why Adoption Is Still Struggling and What We Can Do About It
5